Quick Takeaways
- Barry J. Simon has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $16,909,279.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Barry J. Simon
- Location
- Cardiff By The Sea, CA
- Summary
- The estimated net worth of Barry J. Simon is at least $16,909,279 dollars as of 26 Feb 2026. Barry J. Simon is the Director of ImmunityBio, Inc. and owns shares of ImmunityBio, Inc. (IBRX) stock worth about $16.91M.
- Signature
- /s/ Philip LoScalzo, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Barry J. Simon and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: ImmunityBio, Inc. ($16,909,279).
- Past-year value change for that position: -$1,783,602.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Barry J. Simon
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | Director | $16,909,279 | -$1,783,602 | -9.5% | 24 Feb 2026 |
| VIRX | Viracta Therapeutics, Inc. | Director | 20 Jun 2024 |
Insider Transactions Reported by Barry J. Simon:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.